Description

1-[(4-Bromo-2-Chlorophenoxy)Acetyl]-3,5-Dimethyl-1H-Pyrazole is a high-purity, advanced pharmaceutical intermediate with a defined molecular structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in research and development for new therapeutic agents. It is primarily sought by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries for building complex molecular architectures.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of potential drug candidates, especially in medicinal chemistry programs.
• Agrochemical Research: Used in the development of new herbicides or plant growth regulators, leveraging its halogenated phenoxy moiety.
• Chemical Synthesis: Serves as a versatile precursor for further functionalization in organic synthesis, including cross-coupling reactions.
• Material Science: Potential intermediate for creating specialized polymers or ligands with specific electronic properties.
• Academic & Industrial R&D: Essential for exploratory research in heterocyclic and organohalogen chemistry.

Basic Information

Product Name	1-[(4-Bromo-2-Chlorophenoxy)Acetyl]-3,5-Dimethyl-1H-Pyrazole
CAS No.	587841-52-9
Molecular Formula	C₁₃H₁₂BrClN₂O₂
Molecular Weight	343.60 g/mol
Synonyms	1-[(4-Bromo-2-chlorophenoxy)acetyl]-3,5-dimethyl-1H-pyrazole; 1-(4-Bromo-2-chlorophenoxyacetyl)-3,5-dimethylpyrazole; 3,5-Dimethyl-1-[(4-bromo-2-chlorophenoxy)acetyl]-1H-pyrazole; 1H-Pyrazole-1-acetic acid, 3,5-dimethyl-, 4-bromo-2-chlorophenyl ester; (4-Bromo-2-chlorophenoxy)acetic acid 3,5-dimethylpyrazol-1-yl ester
EINECS	Contact for details

Quality Control

Our production of 1-[(4-Bromo-2-Chlorophenoxy)Acetyl]-3,5-Dimethyl-1H-Pyrazole adheres to stringent in-process controls and final release testing to ensure batch-to-batch consistency and high purity. We provide comprehensive Certificates of Analysis (COA) with each batch, detailing purity, identity, and impurity profiles. Our quality management system supports cGMP standards for pharmaceutical intermediates, ensuring traceability and reliability for critical R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong oxidizing agents, strong acids, and strong bases. For long-term storage, consider under an inert atmosphere to maintain product integrity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.